• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Ligand Pharmaceuticals (LGND)

Common Shares
Sell: $295.00|Buy: $328.88|Change: 5.42 (1.71%)

Open 

$319.22

Previous close 

$317.33

Trade high 

$324.90

Volume 

344,311

Year high 

$326.63

Year low 

$175.89

Dividend yield 

–

Market capitalisation 

$6.43 bn

P/E ratio 

32.77

ISIN 

US53220K5048

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Share price

Performance 31/10/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Ligand Pharmaceuticals+ 1.71
More...

Company profile

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.

Sector 

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.